Allogene Therapeutics Inc - ALLO - stock price prediction, stock price target, analyst ratings from 15 analysts
Allogene Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of -50.0%, and profit growth estimate of 1.4% for FY25, based on top 15 analyst calls.